期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

腰硬联合麻醉前输注万汶预防剖宫产低血压效果观察 被引量：4

下载PDF
导出
摘要 选择ASAⅠ-Ⅱ级择期行剖宫产术的妊娠足月的产妇80例，腰硬麻醉前分别给予乳酸钠林格氏液（A组）和万汶（B组）预防麻醉后低血压。麻醉后两组产妇血压均有所降低，但两组间各时点比较无统计学差异；两组麻醉前后心率变化均无明显差异；A、B组麻醉后分别有22、9例出现低血压，均给予麻黄素10mg后纠正。提示万汶较平衡液具有更好的扩容效果，麻醉前输注万汶可明显减少低血压的发生率。
作者 车向明
机构地区 首都医科大学附属北京妇产医院
出处 《山东医药》 CAS 北大核心 2008年第27期82-83,共2页 Shandong Medical Journal
关键词 麻醉 剖宫产术 低血压 羟乙基淀粉
分类号 R614 [医药卫生—麻醉学]
  • 相关文献

参考文献3

  • 1Gajraj NM, Victory RA. Comparison of an ephedrine infusion with crystalloid administration for prevention of hypotension during spinal anesthesia [J]. Anesth Analg, 1993,76(5) :1023-1026.
  • 2周俊,杨承祥.临床应用万汶的安全性与特点[J].国际麻醉学与复苏杂志,2006,27(5):296-299. 被引量：18
  • 3Haisch G, Boldt J, Krebs C, et al. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery [J]. Anesth Analg, 2001,92(3) :565-571.

二级参考文献23

  • 1Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg,2003,96(5) : 1453-1459.
  • 2Kasper SM,Meinert P, Kampe S, et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology, 2003, 99( 1 ):42-47.
  • 3Haisch G, Boldt J, Krebs C, et al. Influence of a new hydroxyethylstarch preparation (HES 130/0.4 ) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2001,15 ( 3 ) : 316-321.
  • 4Leuschner J, Opitz J, Winkler A,et al. Tissue storage of 14C-lablled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs RD ,2003,4(6) :331-338.
  • 5Woessner R, Grauer MT, Dieterich HJ, et al. Influence of a long-term, high dose volume therapy with6% hydroxyethyl starch 130/0.4 or crystalloid solution onhemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Pathohysiol Haemost Thromb, 2003, 33(3) :121-126.
  • 6Dieterich H J, Nohe B, Deschner N. Modulation of phagocytosis and endothelial function. Anasthesiol Intensivmed Noffallmed Schmerzther,1998,33(4) :270-274.
  • 7Lochbuhler H, Galli C, Hagemann H. Hydroxyethyl starch HES 130/0.4 in paediatric surgery : results of an explorative, controlled, multic enter safety study. Crit Care,2003,7 (2) : 107-110.
  • 8Haisch G, Boldt J, Krebs C,et al. The influence of intravascular volune therapy with a new hydroxyethyl starch preparation (6% HES 130/ 0.4 ) on coagulation in patients undergonging major abdominal surgery.Anesth Analg,2001,92(3) :565-571.
  • 9Jungheinrich C, Sauermann W, Beperling F, et al. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4(6% ) with an optimised in vivo molecular weight in orthopadeic surgery : a randomized, double-blind study. Drugs RD ,2004,5(1):1-9.
  • 10Langeron O, Doelberg M, Ang ET,et al. Voluven, a lower substituted novel hydroxyethyl starch ( HES 130/0.4 ) causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg,2001,92(4) :855-862.

共引文献17

同被引文献34

引证文献4

二级引证文献24

山东医药
2008年 第27期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部